Investing Ideas
/
Global High Growth Potential Companies

Global High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

8527

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

8,527 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
MX1 Micro-X	AU$0.078	-12.4%	-37.6%	AU$45.4m	AU$0.19	PS3x	E68.7%	n/a	Healthcare
FND Findi	AU$4.33	-8.8%	169.8%	AU$212.6m	AU$9.00	PS3.2x	E110.7%	n/a	Diversified Financials
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E	ج.م3.60	6.2%	79.0%	ج.م5.6b	ج.م5.02	PE20.3x	E30.7%	1.9%	Pharmaceuticals & Biotech
FWRY Fawry for Banking Technology and Electronic PaymentsE	ج.م8.60	-0.2%	62.9%	ج.م29.0b	ج.م12.45	PE23.7x	E27.4%	n/a	Diversified Financials
GUINNESS Guinness Nigeria	₦77.00	10.0%	20.9%	₦168.7b	₦74.24	PS0.4x	E119.5%	0%	Food, Beverage & Tobacco
ARES Ares Management	US$198.08	1.1%	61.5%	US$60.6b	US$195.00	PE92.5x	E38.4%	1.9%	Diversified Financials
KINS Kingstone Companies	US$16.60	7.9%	412.3%	US$200.4m	US$18.00	PE12.9x	E24.9%	0%	Insurance
LAVV3 Lavvi Empreendimentos Imobiliários	R$8.52	10.4%	10.6%	R$1.6b	R$12.65	PE5.4x	E20.5%	3.3%	Real Estate Management and Development
AXSM Axsome Therapeutics	US$108.85	4.8%	16.5%	US$5.1b	US$132.13	PS15.6x	E58.1%	n/a	Pharmaceuticals & Biotech
ZVRA Zevra Therapeutics	US$8.02	-1.0%	34.6%	US$419.5m	US$20.63	PS17.5x	E57.8%	n/a	Pharmaceuticals & Biotech
ONON On Holding	US$63.62	5.2%	137.4%	US$20.2b	US$62.47	PE147x	E29.7%	n/a	Consumer Durables
PRL Propel Holdings	CA$40.63	0.1%	150.3%	CA$1.6b	CA$45.92	PE25.2x	E38.9%	1.5%	Diversified Financials
TVTX Travere Therapeutics	US$21.05	1.2%	144.8%	US$1.8b	US$28.47	PS9x	E62.1%	n/a	Pharmaceuticals & Biotech
TGTX TG Therapeutics	US$33.36	14.9%	97.6%	US$4.8b	US$40.33	PS18.1x	E43.6%	n/a	Pharmaceuticals & Biotech
ALNY Alnylam Pharmaceuticals	US$277.16	0.6%	58.4%	US$35.3b	US$299.74	PS17.1x	E56.7%	n/a	Pharmaceuticals & Biotech
300848 Miracll ChemicalsLtd	CN¥16.77	-0.2%	71.7%	CN¥6.9b	CN¥15.00	PE100.6x	E80.2%	0.5%	Materials
002827 Tibet GaoZheng Explosive	CN¥24.16	-0.1%	95.9%	CN¥6.7b	n/a	PE53.1x	E46.7%	0.6%	Materials
002506 GCL System Integration Technology	CN¥2.49	-2.7%	8.7%	CN¥14.5b	CN¥3.51	PE149.5x	E88.9%	n/a	Semiconductors
600211 Tibet Rhodiola Pharmaceutical Holding	CN¥35.99	0.8%	23.4%	CN¥11.6b	n/a	PE15.7x	E25.7%	4.3%	Healthcare
300286 AcrelLtd	CN¥19.48	-3.2%	10.3%	CN¥4.1b	CN¥33.30	PE22.2x	E32.0%	1.0%	Capital Goods
600760 AVIC Shenyang Aircraft	CN¥46.56	-0.8%	35.6%	CN¥128.3b	CN¥53.90	PE52.1x	E29.4%	0.6%	Capital Goods
605499 Eastroc Beverage(Group)	CN¥243.15	0.8%	88.0%	CN¥126.4b	CN¥262.72	PE40.9x	E25.1%	0.8%	Food, Beverage & Tobacco
ALKT Alkami Technology	US$36.07	1.4%	45.3%	US$3.6b	US$45.10	PS11.5x	E102.7%	n/a	Software
RCEL AVITA Medical	US$9.47	5.8%	-46.0%	US$248.5m	US$17.08	PS4.2x	E51.9%	n/a	Pharmaceuticals & Biotech

Page 1 of 356